NASDAQ:PFXNZ PhenixFIN Co. 5.25% Notes due 2028 (PFXNZ) Stock Price, News & Analysis $22.48 +0.25 (+1.12%) (As of 09/16/2024 ET) Add Compare Share Share Today's Range$22.14▼$22.4850-Day Range$22.02▼$22.5752-Week Range$20.50▼$22.80Volume2,208 shsAverage Volume1,790 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendFinancialsSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsDividendFinancialsSEC FilingsShort InterestTrends Get PhenixFIN Co. 5.25% Notes due 2028 alerts: Email Address Ad True Gold RepublicCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold. Click here now to get your free 'Protect Your Wealth' Guide. About PhenixFIN Co. 5.25% Notes due 2028medley capital corp (mcc) is a financial services company located in 375 park ave, new york, new york, united states.Read More PFXNZ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PFXNZ Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive PFXNZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PhenixFIN Co. 5.25% Notes due 2028 and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 8/1 Dividend7/15/2024Dividend Payable8/01/2024Today9/16/2024Ex-Dividend for 11/1 Dividend10/11/2024Dividend Payable11/01/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Sector-- Industry - Sub-IndustryN/A Current SymbolNASDAQ:PFXNZ CUSIPN/A CIK1490349 Webwww.medleycapitalcorp.com Phone12127590777FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key CompetitorsAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028NASDAQ:ABLLLAbrdn Global Infrastructure Income FundNYSE:ASGIAimei Health TechnologyNASDAQ:AFJKRAlphaTime AcquisitionNASDAQ:ATMCRArgo Blockchain plc 8.75% Senior Notes due 2026NASDAQ:ARBKLView All Competitors PFXNZ Stock Analysis - Frequently Asked Questions How have PFXNZ shares performed this year? PhenixFIN Co. 5.25% Notes due 2028's stock was trading at $22.33 at the beginning of 2024. Since then, PFXNZ stock has increased by 0.7% and is now trading at $22.48. View the best growth stocks for 2024 here. How do I buy shares of PhenixFIN Co. 5.25% Notes due 2028? Shares of PFXNZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PFXNZ) was last updated on 9/16/2024 by MarketBeat.com Staff From Our Partners44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. Th...Brownstone Research | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredNvidia needs these 3 companies on a new $1 trillion SuperprojectNvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And i...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PhenixFIN Co. 5.25% Notes due 2028 Please log in to your account or sign up in order to add this asset to your watchlist. Share PhenixFIN Co. 5.25% Notes due 2028 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.